Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00192439 · ClinicalTrials.gov registry record
Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk
A clinical trial of Severe Respiratory Disease, sponsored by MedImmune.
- Completed
- Registry status
- 1,500
- Enrollment target
- 20
- Study locations
NCT00192439 is a study of Severe Respiratory Disease that has completed, run by MedImmune. The registered enrollment target is 1,500 participants. The trial reports 20 study locations across 15 states.
The verdict
NCT00192439, a study of Severe Respiratory Disease, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 1,500 participants
- Enrollment target
- 20
- Study locations
Study Summary
\- Estimate the incidence rate of hMPV infection detected by RT-PCR from frozen nasal wash aspirates in children at high risk for severe LRI disease (hospitalized at \<2 years of age).
Conditions Studied
Interventions
- BEHAVIORAL High Risk Respiratory Disease
Study Locations (20)
New York
- The Children's Hospital - Buffalo
- Schneider Children's Hospital, Long Island Jewish Medical Center - New Hyde Park
- Univ. of Rochester Medical Center - Rochester
- Suny Upstate Medical Univ. - Syracuse
North Carolina
- Duke University Medical Center - Durham
- Wake Forest Univ. School of Medicine - Winston-Salem
Texas
- Univ. of Texas Southwestern Medical Center - Dallas
- Baylor College of Medicine - Houston
California
- Miller Children's Hospital - Long Beach
Colorado
- The Children's Hospital - Denver
Illinois
- Children's Memorial Hospital - Chicago
Massachusetts
- New England Medical Center - Boston
Pennsylvania
- Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2003-12 |
| Est. Completion | 2006-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00192439
The ClinicalTrials.gov registry entry for NCT00192439 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Severe Respiratory Disease appearing as the primary indexed condition, and to 1 intervention - of which High Risk Respiratory Disease is the first listed.
NCT00192439 reports 20 study locations spanning 15 distinct geographic areas - top geographies include New York, North Carolina, Texas.
Frequently Asked Questions
What is clinical trial NCT00192439 about?
NCT00192439 is a clinical study titled "Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk". \- Estimate the incidence rate of hMPV infection detected by RT-PCR from frozen nasal wash aspirates in children at high risk for severe LRI disease (hospitalized at \<2 years of age).
What is the current status of trial NCT00192439?
This trial is currently completed. The enrollment target is 1,500 participants. The study started on 2003-12. Estimated completion is 2006-12.
What conditions does trial NCT00192439 study?
This clinical trial studies the following conditions: Severe Respiratory Disease.
What interventions are being tested in trial NCT00192439?
The interventions under investigation include: High Risk Respiratory Disease (BEHAVIORAL).
Who is sponsoring clinical trial NCT00192439?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00192439 being conducted?
This trial has 20 study locations across California, Colorado, Illinois, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.